Angela Polk
Payments from drug & device makers
Across 193 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$711
- GSK$405
- Boehringer Ingelheim$402
- Sanofi$371
- United Therapeutics Corporation$299
- Mylan Specialty L.p.$219
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,288100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $711 |
| GSK | 28 | $405 |
| Boehringer Ingelheim | 16 | $402 |
| Sanofi | 9 | $371 |
| United Therapeutics Corporation | 7 | $299 |
| Mylan Specialty L.p. | 11 | $219 |
| Insmed, Inc. | 16 | $217 |
| Bayer | 5 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $191 |
| Merck | 8 | $171 |
| Grifols USA, LLC | 6 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Amgen | 5 | $88 |
| Pfizer | 4 | $73 |
| AbbVie | 4 | $70 |
| Solventum Corporation | 3 | $63 |
| Baxter Healthcare | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 2 | $55 |
| Aurinia Pharma U.S., Inc. | 3 | $43 |
| Smith+Nephew | 1 | $42 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $37 |
| Resmed Corp | 2 | $32 |
| Ultragenyx Pharmaceutical Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $28 |
| W. L. Gore & Associates, Inc. | 1 | $27 |
| Abbott | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $16 |
| Gilead | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Merz North America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,305 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 395 | $319,773 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 67 | $55,119 |
| Spiriva RespimatTiotropium Bromide | 44 | $28,728 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 49 | $23,050 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 29 | $15,559 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 562 | $12,386 |
| EliquisApixaban | 17 | $10,273 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $9,856 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $8,690 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 41 | $6,567 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $4,111 |
| Arnuity ElliptaFluticasone Furoate | 11 | $3,341 |
| Ventolin HfaAlbuterol Sulfate | 46 | $3,195 |
| Wixela InhubFluticasone Propion/Salmeterol | 18 | $2,453 |
| Montelukast Sodium | 198 | $2,008 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $405 | $356,021471 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $711 | $63,80895 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $402 | $44,28773 claims |
| PfizerEliquis | $73 | $10,27317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Macon
- Villanueva SpiveyMacon$18K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.